The British Society for Antimicrobial Chemotherapy is working with the pharmaceutical industry to establish a series of antibiotic and antimicrobial resistance surveillance programmes. Image: microscope
The British Society for Antimicrobial Chemotherapy provides results from antibiotic resistance and antimicrobial resistance surveillance programmes. Image: British Society for Antimicrobial Chemotherapy Logo
The British Society for Antimicrobial Chemotherapy also offers analyses of the data in MRSA and MIC distributions. Image: British Society for Antimicrobial Chemotherapy Resistence Surviellance Website

 

Bacteraemia Home

 
Organism
Antimicrobial
Year
Country
Summary

Bactaeremia Data Notices

Title Text External Link
FINDING BACTERAEMIA DATA
2100-03-10

FINDING BACTERAEMIA DATA

Make your selection of organism, season, antimicrobial, country and summary, then click on one of the search buttons. Results can appear here (this tab) or in a new tab/window (new tab). 
 
MORE INFORMATION
2010-03-10

MORE INFORMATION

More information about the Bacteraemia Data will be presented in this space in the future. Meanwhile, please refer to the FAQs - see link on left.
 
Why can't I get data on Acinetobacter and Citrobacter after 2007?
2010-03-09

Why can't I get data on Acinetobacter and Citrobacter after 2007?

Up to 2007, we collected a miscellaneous ?other Gram-negative bacteria? group, which yielded Serratia, Citrobacter and Acinetobacter amongst many other even less common organisms. Mostly, they were too few for meaningful analysis. From 2008, the protocol was changed to collect only Serratia in this group.
 
Why can't I get data on S. epidermidis and S. haemolyticus after 2005?
2010-03-09

Why can't I get data on S. epidermidis and S. haemolyticus after 2005?

These species are still included in the coagulase-negative staphylococci organism group. From 2006 onwards, coagulase-negative staphylococci were not identified to species level, so data on individual species are not available.
 
Why were tigecycline MICs higher in 2002 than later years?
2010-03-08

Why were tigecycline MICs higher in 2002 than later years?

We think this is an experimental artefact. Tigecycline is somewhat oxygen-labile, but this was not fully understood in 2002 when it was quite a new developmental agent. Its laboratory handling requirements were better understood from 2003 onwards, and the MICs obtained since then are more reliable.